RegenETP Inc. (RGTPQ)

Market Cap	66.39K
Revenue	814,000
Net Income	-7.83M
Shares Out	6.85M
EPS	-1.67
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	214
Open	n/a
Previous Close	0.0203
Day's Range	n/a
52-Week Range	n/a
Beta	0.82
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About RGTPQ

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, o...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Aug 13, 1999
• Employees: 42
• Stock Exchange: OTCMKTS
• Ticker Symbol: RGTPQ

Financial Performance

In 2022, RegenETP's revenue was $814,000, a decrease of -91.34% compared to the previous year's $9.40 million. Losses were -$7.83 million, -74.05% less than in 2021.